Aidoc expands its partnership with GLEAMER

GLEAMER’s ChestView solution strengthens Aidoc’s capabilities to meet the rising demand for chest imaging amidst a radiology workforce crisis across Europe.

Aidoc, the leading provider of healthcare AI solutions, today announced a partnership expansion with GLEAMER, a leading European MedTech company pioneering the use of AI technology in the practice of radiology, to integrate their ChestView AI solution for X-ray. ChestView AI detects and notifies for suspected findings of pneumothorax, pleural effusion, consolidations, mediastinal mass and lung nodules which can be potential signs of lung cancer.

With this expanded partnership, Aidoc firmly establishes itself as the exclusive platform provider of a complete AI suite for chest imaging across both CT and X-ray. These advanced capabilities are powered by Aidoc’s award-winning aiOS platform, which seamlessly integrates into the existing IT infrastructure within healthcare organisations, enabling the implementation of AI at scale. Aidoc’s AI offering in the chest imaging space is complimented by its EMR-integrated patient follow-up tools, designed to ensure appropriate follow-up, reducing the risk of patients accidentally leaking from treatment pathways.

“This extended partnership with Aidoc is another major step in our collaboration started in 2021 showing the success of the partnership and trust built between our teams,” says Christian Allouche, CEO & Co-Founder of GLEAMER. “We are thrilled to extend the GLEAMER portfolio accessible to our joint customers to improve patient care and elevate radiologists and physicians to augmented radiology reading.”

This partnership couldn’t come at a better time, with the UK government unveiling its £21 million AI Diagnostic Fund (AIDF) to expedite artificial intelligence (AI) integration into the NHS by winter this year. With over 600,000 chest X-rays performed each month in England and 99% of imaging departments unable to meet reporting demand, this collaboration signifies Aidoc’s commitment to substantial investment in the deployment of AI technology. It underscores Aidoc’s leadership in the industry and its dedication to empowering healthcare professionals with cutting-edge tools for earlier cancer diagnoses, ultimately leading to improved patient outcomes.

“Considering the immense backlog of chest x-rays across hospitals in the UK, the integration of GLEAMER’s ChestView is an essential step in tackling some of the real challenges facing our NHS right now,” says Mike Burns Sales Director for UK & Ireland at Aidoc. “Powered by the enterprise-grade scalability of our AI platform, GLEAMER’s ChestView solution is another highly valued addition to our suite of industry-leading AI solutions that, combined, empower health systems to improve patient outcomes across multiple modalities and departments.”

Previous ArticleNext Article